Clinical Trial

How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants

Name: How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants — clinical trial record (NCT07573449)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the absorption, metabolism and excretion of \[14C\]-JNT-517 and to characterize and determine the metabolites present in plasma, urine, and feces in healthy male participants following a single oral administration.

Trial Details

NCT Number	NCT07573449
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Healthy Volunteers
Enrollment	8 participants
Start Date	2024-01-22
Primary Completion	2025-01-22 (estimated)
Study Completion	2025-02-27 (estimated)
Updated on ClinicalTrials.gov	2026-05-07